| Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis KA Powers, C Poole, AE Pettifor, MS Cohen The Lancet infectious diseases 8 (9), 553-563, 2008 | 485 | 2008 |
| Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection CD Pilcher, G Joaki, IF Hoffman, FEA Martinson, C Mapanje, PW Stewart, ... Aids 21 (13), 1723-1730, 2007 | 377 | 2007 |
| The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study KA Powers, AC Ghani, WC Miller, IF Hoffman, AE Pettifor, G Kamanga, ... The Lancet 378 (9787), 256-268, 2011 | 351 | 2011 |
| Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? MS Cohen, MK Smith, KE Muessig, TB Hallett, KA Powers, AD Kashuba The Lancet 382 (9903), 1515-1524, 2013 | 301 | 2013 |
| Role of acute and early HIV infection in the sexual transmission of HIV WC Miller, NE Rosenberg, SE Rutstein, KA Powers Current Opinion in HIV and AIDS 5 (4), 277-282, 2010 | 261 | 2010 |
| The year-long effect of HIV-positive test results on pregnancy intentions, contraceptive use, and pregnancy incidence among Malawian women IF Hoffman, FEA Martinson, KA Powers, DA Chilongozi, ED Msiska, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 47 (4), 477-483, 2008 | 165 | 2008 |
| Community viral load as a measure for assessment of HIV treatment as prevention WC Miller, KA Powers, MK Smith, MS Cohen The Lancet infectious diseases 13 (5), 459-464, 2013 | 146 | 2013 |
| HIV treatment as prevention: debate and commentary—will early infection compromise treatment-as-prevention strategies? MS Cohen, C Dye, C Fraser, WC Miller, KA Powers, BG Williams PLoS medicine 9 (7), e1001232, 2012 | 135 | 2012 |
| Antiviral agents and HIV prevention: controversies, conflicts, and consensus MS Cohen, KE Muessig, MK Smith, KA Powers, ADM Kashuba Aids 26 (13), 1585-1598, 2012 | 124 | 2012 |
| Rapid, real-time detection of acute HIV infection in patients in Africa SA Fiscus, CD Pilcher, WC Miller, KA Powers, IF Hoffman, M Price, ... The Journal of infectious diseases 195 (3), 416-424, 2007 | 121 | 2007 |
| HIV-1 treatment as prevention: the good, the bad, and the challenges K Smith, KA Powers, ADM Kashuba, MS Cohen Current Opinion in HIV and AIDS 6 (4), 315-325, 2011 | 119 | 2011 |
| Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm KA Powers, WC Miller, CD Pilcher, C Mapanje, FEA Martinson, SA Fiscus, ... Aids 21 (16), 2237-2242, 2007 | 118 | 2007 |
| Kinetics of hepatitis C virus reinfection after liver transplantation KA Powers, RM Ribeiro, K Patel, S Pianko, L Nyberg, P Pockros, ... Liver Transplantation 12 (2), 207-216, 2006 | 100 | 2006 |
| Pharmacodynamics of PEG‐IFN α differentiate HIV/HCV coinfected sustained virological responders from nonresponders AH Talal, RM Ribeiro, KA Powers, M Grace, C Cullen, M Hussain, ... Hepatology 43 (5), 943-953, 2006 | 98 | 2006 |
| HIV treatment as prevention: the utility and limitations of ecological observation MK Smith, KA Powers, KE Muessig, WC Miller, MS Cohen PLoS medicine 9 (7), e1001260, 2012 | 88 | 2012 |
| Does ART prevent HIV transmission among MSM? KE Muessig, MK Smith, KA Powers, YR Lo, DN Burns, AE Grulich, ... Aids 26 (18), 2267-2273, 2012 | 87 | 2012 |
| Dynamics of alanine aminotransferase during hepatitis C virus treatment RM Ribeiro, J Layden-Almer, KA Powers, TJ Layden, AS Perelson Hepatology 38 (2), 509-517, 2003 | 85 | 2003 |
| The detection and management of early HIV infection: a clinical and public health emergency MK Smith, SE Rutstein, KA Powers, S Fidler, WC Miller, JJ Eron Jr, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 63, S187-S199, 2013 | 77 | 2013 |
| Incident HIV among pregnant and breast-feeding women in sub-Saharan Africa: a systematic review and meta-analysis LA Graybill, M Kasaro, K Freeborn, JS Walker, C Poole, KA Powers, ... Aids 34 (5), 761-776, 2020 | 71 | 2020 |
| Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2b KA Powers, NM Dixit, RM Ribeiro, P Golia, AH Talal, AS Perelson Seminars in liver disease 23 (S 1), 013-018, 2003 | 71 | 2003 |
